Net Income

A new report reveals a 38% drop in ransomware, but the danger is evolving. Hackers now prefer silent, long-term intrusion over noisy encryption.

Bolstered by a top regulatory expert and unique veterinary data, Vivos Inc. is set to file for human trials of its precision injectable cancer treatment.

The expanded credit facility provides fintech leader Upgrade with enhanced capital to scale its consumer lending platform, fueling its rapid market expansion.

A new webinar explores how integrating data into EHRs is overcoming major barriers to improve mental health outcomes. Learn how this tech revolutionizes care.

Kratos will compete in a live fly-off for a massive military contract aimed at fielding 350,000 one-way attack drones, reshaping modern warfare.

TruGolf accelerates its stock repurchase program, signaling faith in its future as it unveils new AI-powered tech in a booming indoor golf market.

ARS Pharma's neffy challenges the EpiPen with new data on efficacy, cost-effectiveness, and patient preference, promising a less intimidating allergy emergency.

Celularity Inc. has secured a $12.2M cash injection by selling tax losses, a move set to accelerate its cutting-edge longevity and regenerative medicine pipeline.

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.

With two high-profile board appointments, Stellaromics signals its ambition to dominate the 3D spatial omics market with its advanced Pyxa™ platform.

A new partnership between GeminiBio and Tolemy Bio introduces aiMOS™, an AI-powered service designed to cut costs and boost consistency in cell therapy production.

A new report, based on $34B in spend data, uncovers massive waste in SaaS, cloud, and mobile, offering a playbook for CIOs to regain control.

With $4.5M donated last year, MAC's iconic lipstick program has evolved from an AIDS crusade into a global force for racial, gender, and environmental justice.

The tech firm launches a dedicated healthcare vertical, using AI to simplify complex EHRs and give clinicians more time for patient care.

The financial services firm posted lower delinquency and loss rates for January, but is it a sign of a healthier consumer or savvy internal strategy?

The drive-thru coffee giant is moving into your kitchen, taking on Starbucks and Nestlé with its new retail line. But can its 'Dutch Luv' succeed on shelves?

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

A new three-year deal with Go Rentals aims to elevate the Hoag Classic's luxury experience, blending high-end service with a powerful philanthropic mission.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

FPX Nickel's massive Baptiste project could supply low-carbon nickel for EVs, but it first needs to win over the public and regulators. Here's what's at stake.